Effectiveness of Homologous and Heterologous COVID-19 Boosters Following Vaccine Against COVID-19–Associated ED/Urgent Care Visits and Hospitalizations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
MMWR. Morbidity and Mortality Weekly Report
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022
MMWR Morb. Mortal. Wkly. Rep. 2022 Apr 01;71(13)495-502, K Natarajan, N Prasad, K Dascomb, SA Irving, DH Yang, M Gaglani, NP Klein, MB DeSilva, TC Ong, SJ Grannis, E Stenehjem, R Link-Gelles, EA Rowley, AL Naleway, J Han, C Raiyani, GV Benitez, S Rao, N Lewis, WF Fadel, N Grisel, EP Griggs, MM Dunne, MS Stockwell, M Mamawala, C McEvoy, MA Barron, K Goddard, NR Valvi, J Arndorfer, P Patel, PK Mitchell, M Smith, AB Kharbanda, B Fireman, PJ Embi, M Dickerson, JM Davis, O Zerbo, AF Dalton, MH Wondimu, E Azziz-Baumgartner, CH Bozio, S Reynolds, J Ferdinands, J Williams, SJ Schrag, JR Verani, S Ball, MG Thompson, BE DixonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.